Name:  ___                      Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
___ is a ___ year-old male referred for the evaluation of
gastric restrictive surgery in the treatment and management of
morbid obesity by his primary care provider ___ Medicine 
in
___.  ___ was seen and evaluated in our ___ clinic on ___ and
___.

___ has class III morbid obesity with weight of 316.1 pounds as
of ___ and initial screen weight of 308.9 pounds at height
of 68 inches and BMI of 48.1. His previous weight loss efforts
have included Weight Watchers, Slim-Fast, Diet Workshop and
self-initiated diets with exercise losing up to 10 pounds but 
his
weight loss efforts have failed to produce significant and/or
lasting results. He has not taken prescription weight loss
medications or used over-the-counter ephedra-containing appetite
suppressants/herbal supplements. He stated that his lowest adult
weight was 185-200 pounds in his late teens and early to
mid-twenties. He weighed 265 pounds ___ years ago, 296 pounds in
___ and 313 pounds ___ year ago. He stated that he has been
struggling with weight for the past ___ years after falling on
ice. Factors contributing to his excess weight include large
portions, late-night eating, convenience eating and lack of
exercise. He does count steps daily and increases his walking. 
He
denied history of eating disorders and he denied binge eating. 
He
does not have clinical diagnosis of depression except situation
around his weight. He is not being seen by a therapist and he 
has
not been admitted for mental health issues, he is not on any
psychotropic medications.

Review of systems is noted for skin tags otherwise he denied
chest pain, shortness of breath, weakness, fatigue, headaches,
visual or hearing changes, dizziness/lightheadedness,
palpitations, abdominal pain, nausea or vomiting, fever/chills,
night sweats, cough, heartburn, dysphagia, bleeding disorders,
hemoptysis, hematemesis, hematochezia, hematuria, dysuria,
diarrhea or constipation. He denied heart disease, asthma,
diabetes, gastroesophageal reflux, thromboembolism, back pain,
osteoarthritis, thyroid or gallbladder disorders.      

 
Past Medical History:
His medical history is significant for:

1)  hypertension
2)  hyperlipidemia with elevated triglycerides
3)  obstructive sleep apnea on CPAP
4)  borderline type 2 diabetes with hemoglobin A1c of 6.2%
5)  h/o urinary bladder stones
6)  hepatic steatosis
7)  h/o gout (no recent flares)
8)  BPH
9)  h/o foot callus
___ h/o right shoulder weakness
11) vitamin D deficiency
12) thrombocytopenia

His only surgical history is noted for tonsillectomy in ___.

 
Social History:
___
Family History:
His family history is noted for father deceased age ___ with
history of stroke; mother deceased age ___ with diabetes and
cancer; sister deceased age ___ brother age ___ with history of
cancer; sister age ___ alive and well.

 
Physical Exam:
Vitals: 98.0 PO 145 / 90 73 18 93 Raa 
Gen: alert and awake, in NAD, sitting comfortably in chair
HEENT: anicteric sclera, MMM, oropharynx clear
Lungs: CTAB, no wheezing, rales, or ronchi
CV: RRR, no m/r/g
ABD: soft, NT, ND, no rebound or guarding, incisions healing
well, c/d/I steris in place
EXT: warm, well-perfused, no edema 

 
Pertinent Results:
___ 03:34AM BLOOD Hct-41.0
___ 01:33PM BLOOD Hct-43.6
___ 09:15AM BLOOD Glucose-136* UreaN-13 Creat-0.9 Na-141 
K-4.1 Cl-101 HCO3-26 AnGap-14
___ 09:15AM BLOOD CK-MB-3 cTropnT-<0.01
___ 09:15AM BLOOD Calcium-8.7 Phos-3.1 Mg-2.1
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was 
evaluated by anaesthesia.  
 The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with an IV morphine 
PCA. Pain was very well controlled. The patient was then 
transitioned to crushed oral pain medication- liquid oxycodone 
and liquid tylenol once tolerating a stage 3 diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. Afterwards, the 
patient was started on a stage 1 bariatric diet, which the 
patient tolerated well. Subsequently, the patient was advanced 
to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Allopurinol ___ mg PO DAILY 
2. ammonium lactate 12 % topical ASDIR 
3. Atorvastatin 40 mg PO QPM 
4. urea 47 % topical BID 
5. Tamsulosin 0.8 mg PO QHS 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
2.  Docusate Sodium 100 mg PO BID:PRN constipation 
(Pt prescribed liquid Colace) 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day 
Refills:*0 
3.  Famotidine 20 mg PO BID 
Please crush 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
4.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every four (4) hours 
Refills:*0 
5.  Allopurinol ___ mg PO DAILY 
Please crush  
6.  ammonium lactate 12 % topical ASDIR  
7.  Atorvastatin 40 mg PO QPM 
Please crush  
8.  urea 47 % topical BID  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity
Obstructive sleep apnea

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___, 

You have undergone a laparoscopic sleeve gastrectomy, recovered 
in the hospital and are now preparing for discharge to home with 
the following instructions:

Discharge Instructions: Please call your surgeon or return to 
the Emergency Department if you develop a fever greater than 101 
F, shaking chills, chest pain, difficulty breathing, pain with 
breathing, cough, a rapid heartbeat, dizziness, severe abdominal 
pain, pain unrelieved by your pain medication, a change in the 
nature or severity of your pain, severe nausea, vomiting, 
abdominal bloating, severe diarrhea, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness, 
swelling from your incisions, or any other symptoms which are 
concerning to you.
Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. Do not drink, drive, or operate 
heavy machinery. You may also take acetaminophen (Tylenol) for 
pain management; do not exceed 4000 mg per 24 hour period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___